
Kimberly R. Jordan
Examiner (ID: 16704)
| Most Active Art Unit | 1205 |
| Art Unit(s) | 2899, 1205, 1617, 1614 |
| Total Applications | 742 |
| Issued Applications | 500 |
| Pending Applications | 101 |
| Abandoned Applications | 141 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16673034
[patent_doc_number] => 20210061797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => ORGANIC SEMICONDUCTING COMONOMER
[patent_app_type] => utility
[patent_app_number] => 17/002805
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/002805 | Organic semiconducting comonomer | Aug 25, 2020 | Issued |
Array
(
[id] => 16749887
[patent_doc_number] => 20210101896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/998660
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998660
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/998660 | Monocyclic compounds useful as GPR120 modulators | Aug 19, 2020 | Issued |
Array
(
[id] => 16955980
[patent_doc_number] => 11059821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
[patent_app_type] => utility
[patent_app_number] => 16/994172
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33005
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994172
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/994172 | 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins | Aug 13, 2020 | Issued |
Array
(
[id] => 17938357
[patent_doc_number] => 11472798
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Compounds
[patent_app_type] => utility
[patent_app_number] => 16/990150
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 52750
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 421
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990150 | Compounds | Aug 10, 2020 | Issued |
Array
(
[id] => 17141649
[patent_doc_number] => 20210309661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => IMIDAZO[1,5-a]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/989254
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16989254
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/989254 | Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders | Aug 9, 2020 | Issued |
Array
(
[id] => 16657354
[patent_doc_number] => 20210053990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => THIENOPYRIMIDINE DERIVATIVES AS ACC INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/986909
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986909
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/986909 | Thienopyrimidine derivatives as ACC inhibitors and uses thereof | Aug 5, 2020 | Issued |
Array
(
[id] => 16621436
[patent_doc_number] => 20210040089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => KRAS MUTANT PROTEIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/986336
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 698
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/986336 | KRAS MUTANT PROTEIN INHIBITORS | Aug 5, 2020 | Abandoned |
Array
(
[id] => 16452460
[patent_doc_number] => 20200361886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => Acesulfame Potassium Compositions and Processes for Producing Same
[patent_app_type] => utility
[patent_app_number] => 16/984338
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984338
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984338 | Acesulfame potassium compositions and processes for producing same | Aug 3, 2020 | Issued |
Array
(
[id] => 16452459
[patent_doc_number] => 20200361885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => Acesulfame Potassium Compositions and Processes for Producing Same
[patent_app_type] => utility
[patent_app_number] => 16/984323
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984323
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984323 | Acesulfame potassium compositions and processes for producing same | Aug 3, 2020 | Issued |
Array
(
[id] => 16452458
[patent_doc_number] => 20200361884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => Acesulfame Potassium Compositions and Processes for Producing Same
[patent_app_type] => utility
[patent_app_number] => 16/984305
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984305
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984305 | Acesulfame potassium compositions and processes for producing same | Aug 3, 2020 | Issued |
Array
(
[id] => 16452461
[patent_doc_number] => 20200361887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => Acesulfame Potassium Compositions and Processes for Producing Same
[patent_app_type] => utility
[patent_app_number] => 16/984356
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984356 | Acesulfame potassium compositions and processes for producing same | Aug 3, 2020 | Issued |
Array
(
[id] => 16900644
[patent_doc_number] => 20210179560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 16/983027
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 144380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/983027 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | Aug 2, 2020 | Abandoned |
Array
(
[id] => 16437050
[patent_doc_number] => 20200354376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => COMPOUND CONTAINING TRICYCLIC HETEROARYL GROUP
[patent_app_type] => utility
[patent_app_number] => 16/937119
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16937119
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/937119 | Compound containing tricyclic heteroaryl group | Jul 22, 2020 | Issued |
Array
(
[id] => 17866956
[patent_doc_number] => 20220289691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => 5-AMINO-SUBSTITUTED PYRAZOLES AND TRIAZOLES AS PEST CONTROL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/628477
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628477 | 5-AMINO-SUBSTITUTED PYRAZOLES AND TRIAZOLES AS PEST CONTROL AGENTS | Jul 16, 2020 | Abandoned |
Array
(
[id] => 16557106
[patent_doc_number] => 20210002254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/931156
[patent_app_country] => US
[patent_app_date] => 2020-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16931156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/931156 | Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof | Jul 15, 2020 | Issued |
Array
(
[id] => 17207716
[patent_doc_number] => 11168075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-09
[patent_title] => Compounds and their use for reducing uric acid levels
[patent_app_type] => utility
[patent_app_number] => 16/928623
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 25566
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 403
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16928623
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/928623 | Compounds and their use for reducing uric acid levels | Jul 13, 2020 | Issued |
Array
(
[id] => 20622570
[patent_doc_number] => 12590067
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => Herbicidal cyclohexanedione derivatives
[patent_app_type] => utility
[patent_app_number] => 17/625836
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7771
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 845
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625836 | Herbicidal cyclohexanedione derivatives | Jul 9, 2020 | Issued |
Array
(
[id] => 17103531
[patent_doc_number] => 11123722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Synthesis and characterization of Ru alkylidene complexes
[patent_app_type] => utility
[patent_app_number] => 16/919704
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14337
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/919704 | Synthesis and characterization of Ru alkylidene complexes | Jul 1, 2020 | Issued |
Array
(
[id] => 19651252
[patent_doc_number] => 12173020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => New-type oxazolidinone compounds and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 17/783003
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4493
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783003
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/783003 | New-type oxazolidinone compounds and preparation method therefor | Jun 30, 2020 | Issued |
Array
(
[id] => 16893154
[patent_doc_number] => 11034687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => BACE1 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/903616
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18334
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16903616
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/903616 | BACE1 inhibitors | Jun 16, 2020 | Issued |